Inventor

PLEISS MICHAEL A

US85 patents

⚠️ This page may combine multiple inventors who share the name “PLEISS MICHAEL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PLEISS MICHAEL A

ELAN PHARM INC

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Inhibitors of leukocyte adhesion

Succinoyl aminopyrazoles and related compounds

Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4

Sulfonylquinoxalone derivatives as bradykinin antagonists

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

α-aminoacetic acid derivatives-α4β7 receptor antagonists

4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

WYETH CORP

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors

Anti-inflammatory compositions and method

ATHENA NEUROSCIENCES INC

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

(unassigned)

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

THE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADSTONE

Substituted benzoxazine and related compounds